A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)
NCT00109135 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2015-09-25
Summary
The purpose of this study is to evaluate the safety and tolerability of an investigational drug that may help individuals to stop smoking.
Conditions
- Smoking
Interventions
- DRUG
-
taranabant
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2005-06-30
- Completion
- 2005-06-30
More Related Trials
-
Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking
NCT00594204 ·Status: COMPLETED ·Phase: PHASE4
-
12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation
NCT00139750 ·Status: COMPLETED ·Phase: PHASE2
-
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
NCT00143364 ·Status: COMPLETED ·Phase: PHASE3
-
A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation
NCT00150241 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Medication as a Potential Smoking Cessation Aid
NCT02265367 ·Status: COMPLETED ·Phase: NA
-
Effects of Chantix on Relapse Prevention for Smoking Cessation
NCT00948649 ·Status: COMPLETED ·Phase: PHASE4
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation
NCT00464165 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
NCT02355665 ·Status: COMPLETED ·Phase: PHASE3
-
Varenicline for Light Smokers
NCT01639560 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of ABT-089 on Smoking Abstinence Symptoms and Reward
NCT01756053 ·Status: TERMINATED ·Phase: PHASE2
-
Test of Novel Drug for Smoking Cessation
NCT02217527 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy
NCT00882375 ·Status: COMPLETED ·Phase: NA
-
Effects of Varenicline on Brain Activity During Nicotine Abstinence
NCT00602927 ·Status: COMPLETED ·Phase: NA
-
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
NCT04634071 ·Status: COMPLETED ·Phase: PHASE2
-
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
NCT00141206 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
NCT00371813 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of a New Nicotine Replacement Therapy
NCT00764439 ·Status: COMPLETED ·Phase: PHASE2
-
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation
NCT00356967 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt
NCT00571805 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Relapse Prevention With Varenicline
NCT00944554 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction
NCT01370356 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
NCT00717093 ·Status: COMPLETED ·Phase: PHASE4